The expression frequency of EGFR in human pancreatic carcinomas is reported as 43% [28] and 68.4% in primary invasive ductal carcinoma of the pancreas [31] with elevated expression of EGFR activating ligands also reported. Here, EGFR is linked to exocrine pancreatic carcinoma.